Cortés PEC, Barrón HL, de Velasco GL, Lacy NRM

Language: Spanish
References: 11
Page: 116-119
PDF size: 159.74 Kb.

ABSTRACT

Gout is a form of inflammatory arthritis caused by deposits of monosodium urate in synovial fluid and other tissues. The classic cutaneous manifestations of this disease are tophi, aggregates uric acid that appear as yellowish papules or subcutaneous nodules that may have unusual locations. This is the case report of a 38 year-old male presenting with papules and subcutaneous nodules that formed large and indurated plaques in the posterior aspect of both thighs and body.

REFERENCES

1. Tunhina N. “Gout”. N Engl J Med 2011; 364: 443-452.

2. Bolzetta F, Veronese N, Manzato E, et al. “Tophaceous gout in the elderly: a clinical case review”. Clin Rheumatol 2012; 31: 1127-1132.

3. Kim SY, Guevara JP, Kim KM, et al. “Hyperuricemia and coronary heart disease: a systematic review and meta-analysis”. Arthritis Care Res 2010; 62(2): 170-80.

4. Cho S, Gwang-Jin K, Jee-Ho C, et al. “Chronic Tophaceous Gout Presenting as Hyperpigmented Nodules in the Limbs of a Patient with Coexisting Psoriasis”. J Dermatol 2001; 28: 433-436.

5. Bernat J, Barberá E, Soriano P. “Pápulas blanquecinas en las manos. Actas Dermosifiliorg”, 2013; 104(4): 349-350.

6. Low LL, Cervantes AG, Melcher WL. “Tophaceous gout as a fungating mass”. Arthritis Rheum 1992; 35: 1399-1400.

7. Schumacher HR. “Bullous tophi in gout”. Ann Rheum Dis, 1977; 36: 91-93.

8. Fam AG, Assaad D. “Intradermal urate tophi”. J Rheumatol, 1996; 24: 1126-1131.

9. Ochoa C, Valderrama V, Mejia J, et al. “Panniculitis: another clinical expression of gout”. Rheumatol Int 2011; 31: 831-835.

10. Barnhill R. Dermatopathology, EUA , McGraw-Hill, 2010: 383-384.

11. Perez-Ruiz F, Calabozo M, Pijoan JI, et al. “Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout”. Arthritis Rheum 2002; 47: 356-360